RO 46-2005 4-(叔丁基)-N-(6-(2-羟基乙氧基)-5-(3-甲氧基苯氧基)嘧啶-4-基)苯磺酰胺
CAS 150725-87-4 MFCD00918670
化学结构图
SMILES: COC1C=C(C=CC=1)OC1C(=NC=NC=1NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)OCCO
化学属性
| Mol. Formula | C23H27N3O6S |
|---|---|
| Mol. Weight | 473.547 |
别名和识别编码
| Chemical Name | RO 46-2005 |
|---|---|
| Chemical Name Translation | 4-(叔丁基)-N-(6-(2-羟基乙氧基)-5-(3-甲氧基苯氧基)嘧啶-4-基)苯磺酰胺 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Clozel M, et al. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993 Oct 21;365(6448):759-761.
- [3]. N.R. Sibson, et al. MRI Determination of the Mechanisms Underlying TNF-a-induced Changes in Cerebral Blood Volume, Tissue Water Diffusion and BBB Permeability. Proc. Intl. Soc. Mag. Reson. Med. 10 (2002)
- [1]. Breu V, et al. In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETBreceptors. FEBS Lett. 1993 Nov 15;334(2):210-214.
- [1]. Breu V, et al. In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETBreceptors. FEBS Lett. 1993 Nov 15;334(2):210-214.
- [2]. Clozel M, et al. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993 Oct 21;365(6448):759-761.
- [3]. N.R. Sibson, et al. MRI Determination of the Me
